Search Browse Earnings

MEDICINOVA INC

Nasdaq:MNOV

Pharmaceutical Preparations·LA JOLLA, CA

Overview All Filings Sum Fin Credit Insiders Governance

Overview All Filings Sum Fin Credit Insiders Governance

Summary Financials

MEDICINOVA INC — SlamSEC

CEO

Iwaki Yuichi

Revenue

$1.0M

+0.0% YoY

FY 2024

Adj. EBITDA

-$9.9M

-988.0% margin

FY 2024

Net Income

-$8.6M

-857.2% margin

FY 2024

EPS (Diluted)

-$0.17

FY 2024

Stock Price

$1.38

+1.5%

2026-03-09

52W Range

$1.13 – $1.96

P/E Ratio

-8.1x

Market Cap

$67.7M

Cash

$51.0M

FY 2024

Total Debt

$9.5M

FY 2011

Net Cash

$41.5M

FY 2011

Enterprise Value

$26.2M

Debt / EBITDA

4.2x

FY 2024

EV / EBITDA

-2.6x

Employees

—